Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Carcinoma, Intraductal, Noninfiltrating

• Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction
• Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial
• DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment
• Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer
• Comparing Supplemental Topical Agents for the Treatment of Acute Radiation Dermatitis in Patients With Breast Cancer
• Metformin and Nightly Fasting in Women With Early Breast Cancer
• Neoadjuvant Therapy of Abiraterone Plus ADT for Intraductal Carcinoma of the Prostate
• Impact of Neoadjuvant Hormonal Therapy on the Surgical Management of Extensive Ductal Carcinomas in Situ
• The Ultrasound-guided Multiple-injection Costotransverse Block for Mastectomy and Primary Reconstructive Surgery.
• Radiotherapy Versus Low-Dose Tamoxifen Following Breast Conserving Surgery for Low-Risk Breast Ductal Carcinoma in Situ
• Topical Afimoxifene in Treating Patients With Breast Cancer Who Have Undergone Radiation Therapy on One Breast
• Abemaciclib in Treating Patients With Surgically Resectable, Chemotherapy Resistant, Triple Negative Breast Cancer
• Hybrid Molecular Imaging of ER in Breast Cancer Patients With DCIS
• Preoperative Palbociclib in Patients With DCIS of the Breast That Are Candidates for Surgery
• Docetaxel Versus Abiraterone as First-line Treatment in mCRPC Patients With Intraductal Carcinoma of the Prostate
• Bexarotene in Preventing Breast Cancer in Patients at High Risk for Breast Cancer
• Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast Surgery
• Testing an Active Form of Tamoxifen (4-hydroxytamoxifen) Delivered Through the Breast Skin to Control Ductal Carcinoma in Situ (DCIS) of the Breast
• Oxybutynin Chloride in Managing Hot Flashes
• Ruxolitinib for Premalignant Breast Disease
• Retinoid 9cUAB30 in Producing a Biologic Effect in Patients With Early Stage Breast Cancer
• Pembrolizumab in High-risk Ductal Carcinoma in Situ (DCIS)
• Effect of High Dose Vitamin D on Cancer Biomarkers and Breast Cancer Tumors
• The PROMISE Study: Duavee in Women With DCIS
• Nelipepimut-S Plus GM-CSF Vaccine Therapy in Treating Patients With Breast Cancer
• Sentinel Lymph Node Identification in the Axilla of Women With Breast Cancer Using Ultrasound and Iron Injection
• A Pre-Surgical PK Study of IM and Intraductally Delivered Fulvestrant
• MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ
• Transdermal or Oral Telapristone Acetate in Treating Patients Undergoing Mastectomy
• Naltrexone RCT for Treatment-Emergent Fatigue in Patients Receiving Radiation Therapy for Breast Cancer
• Pilot Study of Oxytocin and microRNA Identification in NAF, Serum, and Tissue in Women With Breast Cancer
• Study to Assess Perfusion and Patient Satisfaction in Nipple-Areola Mastectomy With Immediate Reconstruction
• Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast Cancer
• Omega-3 Fatty Acid in Treating Patients With Stage I-III Breast Cancer
• Docosahexaenoic Acid in Preventing Recurrence in Breast Cancer Survivors
• Broccoli Sprout Extract in Treating Patients With Breast Cancer
• "Phase II Study of PET Guided Neoadjuvant Chemotherapy (NAC) and Oncotype Guided Hormonal Therapy of Breast Cancer"
• Letrozole in Treating Postmenopausal Women With Ductal Carcinoma in Situ
• Diagnostic Study of Early Breast Cancer Using Ultrasound
• Breast Cancer Chemoprevention by SOM230, an IGF-I Action Inhibitor
• Hormone Therapy Or Chemotherapy Before Surgery Based on Gene Expression Analysis in Treating Patients With Breast Cancer
• Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
• Zoledronic Acid in Aromatase Inhibitor Induced Musculoskeletal Symptoms
• Preoperative Testing of the Anti-Progesterone Mifepristone in Early Stage Breast Cancer
• A Pilot Study of Chemo-prevention of Green Tea in Women With Ductal Carcinoma in Situ
• Study of the Efficacy of Chloroquine in the Treatment of Ductal Carcinoma in Situ (The PINC Trial)
• 4-Hydroxytamoxifen or Tamoxifen Citrate in Treating Women With Newly Diagnosed Ductal Breast Carcinoma in Situ
• Lapatinib for Treatment of Ductal Carcinoma In Situ (DCIS) of the Breast
• Vorinostat in Treating Women With Ductal Carcinoma in Situ of the Breast
• Study Of Intraductal Carboplatin In Women With Ductal Carcinoma In Situ (DCIS)
• A Phase I Prevention Study of Atorvastatin in Women at Increased Risk for Breast Cancer
• Lapatinib Ditosylate in Treating Patients With Ductal Breast Carcinoma In Situ
• Neoadjuvant Herceptin for Ductal Carcinoma In Situ of the Breast
• Effect of Fluvastatin on Biomarkers in Women Who Are Undergoing Surgery for Ductal Carcinoma In Situ or Stage I Breast Cancer
• Tamoxifen or Letrozole in Treating Women With Ductal Carcinoma in Situ
• Internal Radiation Therapy After Lumpectomy in Treating Women With Ductal Carcinoma in Situ
• A Pilot Clinical Trial to Evaluate the Biological Activity of Fulvestrant in Breast Ductal Carcinoma in Situ (DCIS)
• Fulvestrant or Tamoxifen in Treating Postmenopausal Women Who Are Undergoing Surgery for Ductal Carcinoma in Situ of the Breast
• Gefitinib Followed By Surgery in Treating Women With Ductal Carcinoma In Situ of the Breast
• Adjuvant Radiation Therapy Compared With Observation After Surgery in Treating Women With Estrogen Receptor Positive or Progesterone Receptor Positive Ductal Carcinoma In Situ of the Breast Who Are Receiving Tamoxifen or Anastrozole
• Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy